Structure-Based Drug Design Strategies in Medicinal Chemistry

被引：124

作者：

Andricopulo, Adriano D. ^{[1
]}

Salum, Livia B. ^{[1
]}

Abraham, Donald J. ^{[2
]}

机构：

[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil

[2] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Sch Pharm, Dept Med Chem, Richmond, VA 23284 USA

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2009年 / 9卷 / 09期

基金：

巴西圣保罗研究基金会;

关键词：

Structure-based drug design; medicinal chemistry; virtual screening; QSAR; pharmacophores; STRUCTURE-BASED OPTIMIZATION; STRUCTURE-BASED DISCOVERY; PROTEIN-LIGAND COMPLEXES; MOLECULAR-FIELD ANALYSIS; HUMAN CARBONIC-ANHYDRASE; FRAGMENT-BASED QSAR; LEAD OPTIMIZATION; FLEXIBLE DOCKING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHARMACOPHORE MODEL;

D O I：

10.2174/156802609789207127

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A broad variety of medicinal chemistry approaches can be used for the identification of hits, generation of leads, as well as to accelerate the development of high quality drug candidates. Structure-based drug design (SBDD) methods are becoming increasingly powerful, versatile and more widely used. This review summarizes current developments in structure-based virtual screening and receptor-based pharmacophores, highlighting achievements as well as challenges, along with the value of structure-based lead optimization, with emphasis on recent examples of successful applications for the identification of novel active compounds.

引用

页码：771 / 790

页数：20

共 137 条

[31] Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model [J].

Evers, A ;

Klebe, G .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) :5381-5392

[32] EVA: A new theoretically based molecular descriptor for use in QSAR/QSPR analysis [J].

Ferguson, AM ;

Heritage, T ;

Jonathon, P ;

Pack, SE ;

Phillips, L ;

Rogan, J ;

Snaith, PJ .

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (02) :143-152

[33] Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 3. The free energy contribution of structural water molecules in HIV-1 protease complexes [J].

Fornabaio, M ;

Spyrakis, F ;

Mozzarelli, A ;

Cozzini, P ;

Abraham, DJ ;

Kellogg, GE .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (18) :4507-4516

[34] A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicals [J].

Fratev, Filip ;

Benfenati, Emilio .

JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 27 (02) :147-160

[35] Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy [J].

Friesner, RA ;

Banks, JL ;

Murphy, RB ;

Halgren, TA ;

Klicic, JJ ;

Mainz, DT ;

Repasky, MP ;

Knoll, EH ;

Shelley, M ;

Perry, JK ;

Shaw, DE ;

Francis, P ;

Shenkin, PS .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1739-1749

[36]

Gedeck P, 2008, CURR OPIN DRUG DISC, V11, P569

[37] Structure-based virtual screening of chemical libraries for drug discovery [J].

Ghosh, Sutapa ;

Nie, Aihua ;

An, Jing ;

Huang, Ziwei .

CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (03) :194-202

[38] CYCLOTHIALIDINE AND ITS CONGENERS - A NEW CLASS OF DNA GYRASE INHIBITORS [J].

GOETSCHI, E ;

ANGEHRN, P ;

GMUENDER, H ;

HEBEISEN, P ;

LINK, H ;

MASCIADRI, R ;

NIELSEN, J .

PHARMACOLOGY & THERAPEUTICS, 1993, 60 (02) :367-380

[39] Predicting binding modes, binding affinities and 'hot spots' for protein-ligand complexes using a knowledge-based scoring function [J].

Gohlke, H ;

Hendlich, M ;

Klebe, G .

PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 2000, 20 (01) :115-144

[40]

Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645

← 1 2 3 4 5 6 7 8 9 10 →